F01

· Shanghai Simnova Biotechnology Co.,Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for F01, covering 2024-06-21 to 2024-06-21. Get the full timeline:

Most recent: Clinical Trial Update: F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus [Phase 1]